Why Apoquel Chewable?

The First and Only Chewable Treatment for the Relief of Allergic Itch in Dogs

With a treat-like formulation, it may simplify dosing and help eliminate the stress from giving pills.

*Responses based on owner review of Apoquel tablet and Apoquel chewable product profiles in a survey

Struggling with Giving Pills?

Talk to your vet to see if Apoquel Chewable could be right for your dog. It's easy to give and comes in 3 strengths to suit your dog’s body weight.

Petcare Rewards logo

Control Allergic Itch & Earn Up To $80 in Rewards

Join our free pet health Rewards program. Spend your Rewards on products and services at the vet!

Frequently Asked Questions

IMPORTANT SAFETY INFORMATION: See full Apoquel Tablet and Apoquel Chewable Prescribing Information. Do not use Apoquel or Apoquel Chewable in dogs less than 12 months of age or those with serious infections. Apoquel and Apoquel Chewable may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre- existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post- approval. Apoquel and Apoquel Chewable have not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. Apoquel and Apoquel Chewable have been used safely with many common medications including parasiticides, antibiotics and vaccines.

INDICATIONS: Control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.


  1. Data on file: Study Report A161C-US-21-C02, Zoetis Inc., 2022.
  2. Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5):479- e114. doi: 10.1111/vde.12047.
  3. Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol. 2015;26(3):171-179, e35. doi: 10.1111/vde.12194.
  4. Data on file, TI-09920. ZMR: Adelphi/PROVE Pet Owner Preferences for Pill vs Treat All Markets WTP Survey Results March 2023.
  5. Data on file, TI-09986, Zoetis Inc., 2022.
  6. Data on file, TI-09776, Zoetis Inc., June 2023.
  7. Mueller R, Olivry T, Prélaud P. Critically appraised topic on adverse food reactions of companion animals (2): common food allergen sources in dogs and cats. BMC Veterinary Research [serial online]. 2016;12(9):(12 January 2016). doi:10.1186/s12917-016-0633-8
  8. Cosgrove, SB, et al., Vet Dermatol, 2013 Blinded placebo-controlled client-owned dog trial (AR-00890)